See also this year's filing and all EDGAR filings for this company.
PDF Report 0001062822_2022_Lexicon_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.6988040285354595, 'aggregate_val': 77175000, 'exp_sum': 28596000, 'exp_to_value': {'LiabilitiesCurrent': 23172000, 'LiabilitiesNoncurrent': 5424000, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001062822, Lexicon Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 88,921,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,543,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,176,000 |
| 3 | remainder_Assets | 2,269,000 |
| 4 | LiabilitiesCurrent | 22,124,000 |
| 5 | LiabilitiesNoncurrent | 1,190,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | -1,280,307 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,454,052 |
| 9 | ResearchAndDevelopmentExpense | 91,239,116 |
| 10 | remainder_Expenses | 2,459,631 |
| 11 | remainder_Revenues | 7,579,915 |
| 12 | remainder_NetIncome | 135,497,695 |
| 13 | remainder_ComprehensiveNetIncome | 6,058 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 136,909,000 |
| 1 | Liabilities | 23,314,000 |
| 2 | Expenses | 123,872,492 |
| 3 | Revenues | 7,579,915 |
| 4 | StockholdersEquity | 113,595,000 |
| 5 | NetIncome | 19,205,118 |
| 6 | ComprehensiveNetIncome | 19,208,147 |
| 7 | BaseVar | 213,589,580 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.33 |
| 9 | EconomicCapitalRatio | 3.91 |
Edgar->Model Mapping
Feature Distribution
Change over Time
